Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Cagrilintide is a synthetic, long-acting analogue of amylin, a naturally occurring peptide hormone co-secreted with insulin by pancreatic beta cells. Amylin plays a critical role in metabolic regulation by slowing gastric emptying, suppressing glucagon secretion, and promoting satiety.
Laboratory research with Cagrilintide has focused on its effects on appetite regulation, weight management, and glucose metabolism. Its extended half-life makes it particularly valuable for studies requiring sustained amylin receptor activation. Cagrilintide is also of interest in combination therapy models, especially when paired with incretin receptor agonists such as GLP-1 analogues, where synergistic effects on energy balance and weight regulation have been observed in preclinical and clinical settings.
Cagrilintide is a synthetic, long-acting analogue of amylin, a naturally occurring peptide hormone co-secreted with insulin by pancreatic beta cells. Amylin plays a critical role in metabolic regulation by slowing gastric emptying, suppressing glucagon secretion, and promoting satiety.
Laboratory research with Cagrilintide has focused on its effects on appetite regulation, weight management, and glucose metabolism. Its extended half-life makes it particularly valuable for studies requiring sustained amylin receptor activation. Cagrilintide is also of interest in combination therapy models, especially when paired with incretin receptor agonists such as GLP-1 analogues, where synergistic effects on energy balance and weight regulation have been observed in preclinical and clinical settings.